NCT04182087 Cognitive Function Assessment in Patients With Focal Brain Injury
| NCT ID | NCT04182087 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Grenoble |
| Condition | Focal Brain Injury |
| Study Type | OBSERVATIONAL |
| Enrollment | 400 participants |
| Start Date | 2020-02-07 |
| Primary Completion | 2030-02-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 400 participants in total. It began in 2020-02-07 with a primary completion date of 2030-02-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This research relates to the study of cognitive deficits related to various focal brain lesions and their localizations in the brain. it involves building a large database of behavioural responses measured during the performance of cognitive tasks in patients with focal brain injury, to allow to better understand function of brain.
Eligibility Criteria
Inclusion Criteria: * Male and female patients, 18-70 years old * A single, focal anatomical lesion of a given cerebral territory (post vascular, post surgical resection) documented by MRI * Intellectual ability and understanding of instructions compatible with the cognitive tasks to be performed Exclusion Criteria: * Patient deprived of liberty * Somatic disorder likely to affect cognitive abilities * Pregnant or nursing woman
Contact & Investigator
Philippe Kahane, MD, PhD
PRINCIPAL INVESTIGATOR
University Hospital, Grenoble
Frequently Asked Questions
Who can join the NCT04182087 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 70 Years, studying Focal Brain Injury. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04182087 currently recruiting?
Yes, NCT04182087 is actively recruiting participants. Contact the research team at pkahane@chu-grenoble.fr for enrollment information.
Where is the NCT04182087 trial being conducted?
This trial is being conducted at Grenoble, France.
Who is sponsoring the NCT04182087 clinical trial?
NCT04182087 is sponsored by University Hospital, Grenoble. The principal investigator is Philippe Kahane, MD, PhD at University Hospital, Grenoble. The trial plans to enroll 400 participants.